- Celiac Disease & Gluten Intolerance Research
Celiac Disease & Gluten Intolerance Research
One angle being tried by researchers to treat celiac disease involves oral peptides that would prevent an adverse gluten reaction in people with celiac disease who are following a gluten-free diet.
People with non-celiac gluten sensitivity (NCGS) do not have celiac disease, but their symptoms improve when they are placed on gluten-free diets.
A research team recently set out to determine the risk of celiac disease autoimmunity and celiac disease, by age and by halpotype, in children.
Each year, non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, acetaminophen, and aspirin, send more than 100,000 people to the hospital, and cause over 16,000 deaths. These drugs are marketed under brand names such as Advil, Tylenol, and Bayer, among others.
A team of researchers recently set out to determine if T-cell receptor recognition of HLA-DQ2–gliadin complexes was connected with celiac disease.
Differentiating between celiac disease and non-celiac gluten sensitivity is often challenging. A team of researchers recently set out to assess the best way to tell the difference between the two.
Celiac disease guidelines suggest that some patients with high anti-tTG ab levels might be diagnosed without biopsy.
Drug would protect celiacs on a gluten-free diet against gut damage from small amounts of gluten contamination.
A team of Canadian researchers have discovered a key molecule that could lead to new treatments for celiac disease.
A team of researchers recently set out to assess if patient-centered barriers have a role in stifling serologic screening for celiac disease in individuals from high-risk populations.
Autophagy protein LC3 has recently been implicated in autoantigen formation. However, its role in celiac disease has remained unknown. A new study changes that.
A team of researchers recently set out to compare the performance of antibody tests in predicting small-intestinal mucosal status in diagnosis and follow-up of pediatric celiac disease.
Since the introduction of glyphosate-based herbicides, like Roundup ®, by Monsanto in the 1970s, celiac disease levels have increased 400%. Could these herbicides play a significant role in driving the autoimmune condition that is celiac disease?
A gluten-free diet remains the only treatment for celiac disease, but researchers are looking into new therapies aimed at gluten modification.
Two new studies have confirmed colonization of gluten-degrading bacteria in the human mouth and upper gastrointestinal tracts.
A new blood test under development by researchers at Walter and Eliza Hall Institute can rapidly and accurately diagnose celiac disease without the prolonged gluten exposure needed for current tests.
For many people with celiac disease, one of the numerous downsides of the condition is the constant threat of an adverse reaction triggered by accidental gluten consumption. Because reactions to gluten ingestion can be severe for some celiac patients, many clinicians are looking to see if anything can be done to lessen the effects gluten reactions in celiac patients once they have started.
A team of researchers recently set out to assess the validity and effectiveness of near-patient celiac immunological testing in dietician-led celiac disease follow-up clinics, and to compare the results against standard laboratory immunological techniques.
More and more people are reporting gastrointestinal symptoms that improve when wheat and/or gluten are removed from the diet. There is a diverse group of people who avoid wheat and/or gluten (PWAWGs), and who predominantly self-diagnose prior to presenting for clinical evaluation for celiac disease.
According to a new article by a team of researchers, not all gluten protein is created equal. That is, not all gluten proteins trigger an immune response in people with celiac disease.